Tectonic Therapeutic (TECX) Amortization of Deferred Charges (2017 - 2018)

Tectonic Therapeutic (TECX) reported Amortization of Deferred Charges of $4000.0 for Q4 2018, down 63.64% year-over-year from $11000.0 in Q4 2017, and down 63.64% quarter-over-quarter from $11000.0 in Q3 2018.

Tectonic Therapeutic (TECX) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends

Tectonic Therapeutic (TECX) has 2 years of Amortization of Deferred Charges data on file, last reported at $4000.0 in Q4 2018.

  • Amortization of Deferred Charges for Q4 2018 came in at $4000.0, down 63.64% year-over-year; the trailing twelve-month figure through Dec 2018 was $37000.0 (changed N/A YoY), and the FY2018 annual result was $37000.0, up 54.17% from the prior year.
  • Amortization of Deferred Charges slipped to $4000.0 in Q4 2018 per TECX's latest filing, from $11000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $11000.0 in Q3 2017 and troughed at $4000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Tectonic Therapeutic 528.16 Mn 291.27 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 4,000.00
Dec 31, 2018 4,000.00
Sep 30, 2018 11,000.00
Sep 30, 2018 11,000.00
Jun 30, 2018 11,000.00
Jun 30, 2018 11,000.00
Mar 31, 2018 11,000.00
Mar 31, 2018 11,000.00
Dec 31, 2017 11,000.00
Dec 31, 2017 11,000.00
Sep 30, 2017 11,000.00
Sep 30, 2017 11,000.00